Although a trend toward longer survival was observed in the low-IL-6 group, the difference between the two groups did not reach statistical significance ( p = 0.055, HR: 0.55 (95% CI, 0.29–1.02)) ( Figure 4 ). 3.5.
← all excerpts
Impact of Serum GDF-15 and IL-6 on Immunotherapy Response in Cancer: A Prospective Study.
1
0.0550
0.0550